Doriane Gouas

477 total citations
10 papers, 352 citations indexed

About

Doriane Gouas is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Doriane Gouas has authored 10 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Oncology and 4 papers in Hepatology. Recurrent topics in Doriane Gouas's work include Hepatitis B Virus Studies (10 papers), Cancer-related Molecular Pathways (5 papers) and Hepatitis C virus research (3 papers). Doriane Gouas is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Cancer-related Molecular Pathways (5 papers) and Hepatitis C virus research (3 papers). Doriane Gouas collaborates with scholars based in France, United States and Sweden. Doriane Gouas's co-authors include Pierre Hainaut, Hong Shi, Sandra Ortiz‐Cuaran, Stéphanie Villar, Marlin D. Friesen, John D. Groopman, Isabelle Chemin, Pénélope Legros, Gilles Ferro and Behnoush Abedi‐Ardekani and has published in prestigious journals such as PLoS ONE, Environmental Health Perspectives and Carcinogenesis.

In The Last Decade

Doriane Gouas

10 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doriane Gouas France 9 142 123 113 107 93 10 352
Neng-Jin Wang China 4 118 0.8× 101 0.8× 70 0.6× 110 1.0× 80 0.9× 5 302
Di Qu China 11 100 0.7× 190 1.5× 83 0.7× 102 1.0× 89 1.0× 24 389
Guoting Liu China 5 166 1.2× 80 0.7× 70 0.6× 128 1.2× 64 0.7× 13 395
Gengsun Qian China 11 256 1.8× 91 0.7× 54 0.5× 222 2.1× 71 0.8× 14 431
Abdel-Rahman United States 6 97 0.7× 127 1.0× 50 0.4× 98 0.9× 32 0.3× 13 358
Hong Liang United States 11 59 0.4× 174 1.4× 63 0.6× 33 0.3× 52 0.6× 32 304
Zhiyuan Wu China 9 166 1.2× 79 0.6× 36 0.3× 105 1.0× 47 0.5× 13 304
Shu Feng China 12 189 1.3× 131 1.1× 89 0.8× 146 1.4× 17 0.2× 26 374
Siddhartha Rawat United States 9 221 1.6× 139 1.1× 36 0.3× 164 1.5× 58 0.6× 11 464
Xiaoqiang Chai China 9 44 0.3× 197 1.6× 63 0.6× 39 0.4× 120 1.3× 17 375

Countries citing papers authored by Doriane Gouas

Since Specialization
Citations

This map shows the geographic impact of Doriane Gouas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doriane Gouas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doriane Gouas more than expected).

Fields of papers citing papers by Doriane Gouas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doriane Gouas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doriane Gouas. The network helps show where Doriane Gouas may publish in the future.

Co-authorship network of co-authors of Doriane Gouas

This figure shows the co-authorship network connecting the top 25 collaborators of Doriane Gouas. A scholar is included among the top collaborators of Doriane Gouas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doriane Gouas. Doriane Gouas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Villar, Stéphanie, Sandra Ortiz‐Cuaran, Behnoush Abedi‐Ardekani, et al.. (2012). Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis. PLoS ONE. 7(6). e37707–e37707. 41 indexed citations
2.
Ortiz‐Cuaran, Sandra, Stéphanie Villar, Doriane Gouas, et al.. (2012). Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand. Cancer Letters. 331(1). 46–51. 25 indexed citations
3.
Gouas, Doriane, Stéphanie Villar, Sandra Ortiz‐Cuaran, et al.. (2012). TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis. 33(6). 1219–1224. 34 indexed citations
4.
Gouas, Doriane, Sandra Ortiz‐Cuaran, Pénélope Legros, et al.. (2012). Editorial_Board. Carcinogenesis. 33(6). NP–NP. 36 indexed citations
5.
Villar, Stéphanie, Doriane Gouas, Amelie Plymoth, et al.. (2011). Seasonal Variation in TP53 R249S -Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection. Environmental Health Perspectives. 119(11). 1635–1640. 29 indexed citations
6.
Gouas, Doriane, Stéphanie Villar, Ahmad Besaratinia, et al.. (2011). Interactions between hepatitis B virus and aflatoxin B1: effects on p53 induction in HepaRG cells. Journal of General Virology. 93(3). 640–650. 25 indexed citations
7.
Abedi‐Ardekani, Behnoush, Doriane Gouas, Stéphanie Villar, Masoud Sotoudeh, & Pierre Hainaut. (2011). TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations. PubMed. 2011. 1–6. 6 indexed citations
8.
Galy, Olivier, Isabelle Chemin, Emilie Le Roux, et al.. (2011). Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand. PubMed. 2011. 1–9. 12 indexed citations
9.
Gouas, Doriane, Hong Shi, A. Hautefeuille, et al.. (2010). Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein. Carcinogenesis. 31(8). 1475–1482. 47 indexed citations
10.
Gouas, Doriane, Hong Shi, & Pierre Hainaut. (2009). The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy. Cancer Letters. 286(1). 29–37. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026